Multi-omic rejuvenation of human cells by maturation phase transient reprogramming.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study on cultured human cells
PubMed 35390271 · doi:10.7554/eLife.71624
What was done
Researchers developed a maturation phase transient reprogramming (MPTR) protocol, expressing reprogramming factors in dermal fibroblasts from middle-aged human donors until the maturation phase rejuvenation point, then withdrawing the factors. They evaluated cell identity retention, multi-omic aging markers using a novel transcriptome clock and DNA methylation clocks (along with H3K9me3 levels), collagen protein production, and functional cell migration speed.
What was found
Fibroblasts transiently lost and then regained their somatic identity. The transcriptome was rejuvenated by approximately 30 years according to a novel transcriptome clock, with similar rejuvenation observed in the epigenome (H3K9me3 levels and DNA methylation age). Functional assays showed restored youthful collagen protein production and partial rejuvenation of migration speed. The abstract does not provide exact donor sample sizes, baseline donor ages, or numerical confidence intervals.
Why it matters
This study demonstrates that multi-omic and functional rejuvenation can be separated from complete pluripotency reprogramming in human cells, providing proof of concept for reversing cellular aging phenotypes without permanent loss of cell identity.
Limits
The study is restricted to in vitro cultured dermal fibroblasts; clinical translatability and safety in living organisms remain unknown. The abstract does not report the number of donors, quantitative variance, or potential long-term risks such as oncogenic transformation.
Cited by
- supports During cellular reprogramming, epigenetic age reversal occurs before the cell loses its differentiated identity.
- supports Partial cellular reprogramming in wild-type mice and in cultured cells reverses epigenetic age and improves cellular function.